Sun Pharma Q2 profit rises 28% to ₹3,040 cr
The company’s revenue from operations increased 9% year-on-year to ₹13,291 crore for the second quarter.
sun pharma q2 profit
October 2024
December 2023
November 2022
Sun Pharma revises offer to buy outstanding shares of Taro Pharma; stock falls
Sun proposes to acquire outstanding shares of Taro’s at $43 apiece, up from $38 per share earlier
Sun Pharma Q2 profit rises 10.5% to ₹2,262 cr; revenue up 13%
Sun Pharma MD Dilip Shanghvi says in Q2, Sun Pharma recorded double-digit topline growth and strong margins, driven by market share gain in India, and sustained ramp-up of global specialty biz.
